Early Access — free while we kick the tires
EdgarHawk

Aromando Andrew

Chief Business Officer

Officer
1 filing analyzed · 1 company · Latest 2026-02-13

Companies

Company Buys Sells Direction
ONCOLYTICS BIOTECH INC ONCY 1 0 Net buying

Activity

February 2026
2026-02-13 ONCOLYTICS BIOTECH INC ONCY
high
Buy
29,600 shares
$25,418
Significance 7/10

Chief Business Officer Aromando Andrew bought 29,600 shares of ONCY at $0.86; 8 other insiders also bought within 14 days

Aromando Andrew, Chief Business Officer, purchased 29,600 shares at $0.86 on 2026-02-11, increasing his holdings from 25,500 to 55,100 shares (+116.1%). The transaction occurs within a cluster pattern: 8 other insiders also bought within the past 14 days. This coordinated buying activity across multiple executives suggests alignment on company direction at a time when the stock trades at $1.06, down -25.4% from its 52-week high of $1.42. The concentration of insider purchases over a compressed timeframe is a material signal of insider positioning, particularly given the executive role and the aggregate scale of the cohort activity.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access